Facets (new session)
Description
Metadata
Settings
owl:sameAs
Inference Rule:
b3s
b3sifp
dbprdf-label
facets
http://dbpedia.org/resource/inference/rules/dbpedia#
http://dbpedia.org/resource/inference/rules/opencyc#
http://dbpedia.org/resource/inference/rules/umbel#
http://dbpedia.org/resource/inference/rules/yago#
http://dbpedia.org/schema/property_rules#
http://www.ontologyportal.org/inference/rules/SUMO#
http://www.ontologyportal.org/inference/rules/WordNet#
http://www.w3.org/2002/07/owl#
ldp
oplweb
skos-trans
virtrdf-label
None
About:
Vaccines and Therapeutics Against Hantaviruses
Goto
Sponge
NotDistinct
Permalink
An Entity of Type :
schema:ScholarlyArticle
, within Data Space :
wasabi.inria.fr
associated with source
document(s)
Type:
Academic Article
research paper
schema:ScholarlyArticle
New Facet based on Instances of this Class
Attributes
Values
type
Academic Article
research paper
schema:ScholarlyArticle
isDefinedBy
Covid-on-the-Web dataset
title
Vaccines and Therapeutics Against Hantaviruses
Creator
Lu, Lu
Zhang, Fanglin
Zhang, Qiang
Jin, Xia
Hou, Wei
Cheng, Gong
Han, Mingwei
Liu, Rongrong
Liu, Ziyu
Ma, Hongwei
Shu, Jiayi
Wu, Xingan
source
PMC
abstract
Hantaviruses (HVs) are rodent-transmitted viruses that can cause hantavirus cardiopulmonary syndrome (HCPS) in the Americas and hemorrhagic fever with renal syndrome (HFRS) in Eurasia. Together, these viruses have annually caused approximately 200,000 human infections worldwide in recent years, with a case fatality rate of 5–15% for HFRS and up to 40% for HCPS. There is currently no effective treatment available for either HFRS or HCPS. Only whole virus inactivated vaccines against HTNV or SEOV are licensed for use in the Republic of Korea and China, but the protective efficacies of these vaccines are uncertain. To a large extent, the immune correlates of protection against hantavirus are not known. In this review, we summarized the epidemiology, virology, and pathogenesis of four HFRS-causing viruses, HTNV, SEOV, PUUV, and DOBV, and two HCPS-causing viruses, ANDV and SNV, and then discussed the existing knowledge on vaccines and therapeutics against these diseases. We think that this information will shed light on the rational development of new vaccines and treatments.
has issue date
2020-01-30
(
xsd:dateTime
)
bibo:doi
10.3389/fmicb.2019.02989
bibo:pmid
32082263
has license
cc-by
sha1sum (hex)
ce0425b48e9b111a10f612fc562a2cd316633c15
schema:url
https://doi.org/10.3389/fmicb.2019.02989
resource representing a document's title
Vaccines and Therapeutics Against Hantaviruses
has PubMed Central identifier
PMC7002362
has PubMed identifier
32082263
schema:publication
Front Microbiol
resource representing a document's body
covid:ce0425b48e9b111a10f612fc562a2cd316633c15#body_text
is
schema:about
of
named entity 'REPUBLIC OF KOREA'
named entity 'VIROLOGY'
named entity 'CAUSE'
named entity 'LIGHT'
named entity 'HEMORRHAGIC FEVER WITH RENAL SYNDROME'
named entity 'INACTIVATED VACCINES'
named entity 'APPROXIMATELY'
named entity 'VACCINES'
named entity 'NOT KNOWN'
named entity '40%'
named entity 'SNV'
named entity 'UNCERTAIN'
named entity 'HANTAVIRUSES'
named entity 'IMMUNE'
named entity 'ANNUALLY'
named entity 'HANTAVIRUS'
named entity 'LICENSED'
named entity 'INFECTIONS'
named entity 'WORLDWIDE'
named entity 'THINK'
named entity 'RECENT'
named entity 'NEW'
named entity 'REVIEW'
named entity 'CHINA'
named entity 'VIRUS'
named entity 'CASE FATALITY RATE'
named entity 'AMERICAS'
named entity 'THESE'
named entity 'CURRENTLY'
named entity 'EFFECTIVE'
named entity 'UP TO'
named entity 'HAVE'
named entity 'VACCINES'
named entity 'USE'
named entity 'LARGE EXTENT'
named entity 'YEARS'
named entity 'THERAPEUTICS'
named entity 'EITHER'
named entity 'PATHOGENESIS'
named entity 'PROTECTION'
named entity 'INFORMATION'
named entity 'CARDIOPULMONARY'
named entity 'DISEASES'
named entity 'TREATMENTS'
named entity 'TRANSMITTED'
named entity 'EURASIA'
named entity 'SYNDROME'
named entity 'KNOWLEDGE'
named entity 'RODENT'
named entity 'BUT'
named entity 'DEVELOPMENT'
named entity 'THERAPEUTICS'
named entity 'HANTAVIRUSES'
named entity 'HUMAN'
named entity 'VIRUSES'
named entity 'TREATMENT AVAILABLE'
named entity 'HFRS'
named entity 'EPIDEMIOLOGY'
named entity 'CAUSING'
named entity '200'
named entity 'hemorrhagic fever with renal syndrome'
named entity 'Hantaviruses'
named entity 'Eurasia'
named entity 'case fatality rate'
named entity 'viruses'
named entity 'viruses'
named entity 'rodent'
named entity 'vaccines'
named entity 'efficacies'
named entity 'SEOV'
◂◂ First
◂ Prev
Next ▸
Last ▸▸
Page 1 of 14
Go
Faceted Search & Find service v1.13.91 as of Mar 24 2020
Alternative Linked Data Documents:
Sponger
|
ODE
Content Formats:
RDF
ODATA
Microdata
About
OpenLink Virtuoso
version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software